Canada markets close in 3 hours 31 minutes

Aequus Pharmaceuticals Inc. (AQS.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.0300+0.0050 (+20.00%)
As of 11:03AM EDT. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 3.32M
Enterprise Value 8.75M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)15.41
Price/Book (mrq)N/A
Enterprise Value/Revenue 40.64
Enterprise Value/EBITDA -2.87

Trading Information

Stock Price History

Beta (5Y Monthly) 0.17
52-Week Change 30.00%
S&P500 52-Week Change 326.14%
52 Week High 30.0600
52 Week Low 30.0100
50-Day Moving Average 30.0173
200-Day Moving Average 30.0270

Share Statistics

Avg Vol (3 month) 3136.8k
Avg Vol (10 day) 3346.28k
Shares Outstanding 5132.63M
Implied Shares Outstanding 6132.63M
Float 8112.79M
% Held by Insiders 114.68%
% Held by Institutions 10.00%
Shares Short (Apr 30, 2024) 4311
Short Ratio (Apr 30, 2024) 40.01
Short % of Float (Apr 30, 2024) 4N/A
Short % of Shares Outstanding (Apr 30, 2024) 40.00%
Shares Short (prior month Feb 29, 2024) 4135

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023


Profit Margin 0.00%
Operating Margin (ttm)-1,307.86%

Management Effectiveness

Return on Assets (ttm)-126.92%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)254.9k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-86.70%
Gross Profit (ttm)N/A
Net Income Avi to Common (ttm)-2.96M
Diluted EPS (ttm)-0.0100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)215.05k
Total Cash Per Share (mrq)0
Total Debt (mrq)5.06M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.09
Book Value Per Share (mrq)-0.03

Cash Flow Statement

Operating Cash Flow (ttm)-2.29M
Levered Free Cash Flow (ttm)-1.25M